E-Therapeutics PLC (ETXP.L)

ETXP.L on London Stock Exchange

28.50GBp
10:53am EST
Price Change (% chg)

0.00p (+0.00%)
Prev Close
28.50p
Open
28.50p
Day's High
--
Day's Low
--
Volume
31,000
Avg. Vol
37,059
52-wk High
36.55p
52-wk Low
19.02p

ETXP.L

Chart for ETXP.L

About

e-Therapeutics plc is engaged in the discovery and development of drugs. The Company is a drug discovery and development company with a platform in network pharmacology. The Company’s two drugs in clinical development include ETS2101 (glioma and other cancers; phase I) and ETS6103 (depressive disorder, phase II). ETS6103 is a... (more)

Overall

Beta: 0.72
Market Cap (Mil.): £75.33
Shares Outstanding (Mil.): 264.32
Dividend: --
Yield (%): --

Financials

  ETXP.L Industry Sector
P/E (TTM): -- 212.78 38.55
EPS (TTM): -0.03 -- --
ROI: -15.68 -2.36 17.25
ROE: -15.68 -3.67 18.17
Search Stocks

BRIEF-E-Therapeutics appoints Sean Nicolson as executive director

* Appoints Sean Nicolson to board of directors as an executive director

16 Oct 2014

BRIEF-E-Therapeutics first-half loss widens

* Half year loss before tax of 5.3 million stg (six months to 31 July 2014: loss of 3.1 million stg)

16 Sep 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks